Literature DB >> 21168053

Cytotoxic therapy for severe swine flu A/H1N1.

Jan-Inge Henter1, Kajsa Palmkvist-Kaijser, Bernhard Holzgraefe, Yenan T Bryceson, Kenneth Palmér.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21168053     DOI： 10.1016/S0140-6736(10)61345-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  17 in total

Review 1.  Two years after pandemic influenza A/2009/H1N1: what have we learned?

Authors:  Vincent C C Cheng; Kelvin K W To; Herman Tse; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

2.  A purine metabolic checkpoint that prevents autoimmunity and autoinflammation.

Authors:  Svetlana Saveljeva; Gavin W Sewell; Katharina Ramshorn; M Zaeem Cader; James A West; Simon Clare; Lea-Maxie Haag; Rodrigo Pereira de Almeida Rodrigues; Lukas W Unger; Ana Belén Iglesias-Romero; Lorraine M Holland; Christophe Bourges; Muhammad N Md-Ibrahim; James O Jones; Richard S Blumberg; James C Lee; Nicole C Kaneider; Trevor D Lawley; Allan Bradley; Gordon Dougan; Arthur Kaser
Journal:  Cell Metab       Date:  2022-01-04       Impact factor: 27.287

3.  Whole-Exome Sequencing Reveals Mutations in Genes Linked to Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Fatal Cases of H1N1 Influenza.

Authors:  Grant S Schulert; Mingce Zhang; Ndate Fall; Ammar Husami; Diane Kissell; Andrew Hanosh; Kejian Zhang; Kristina Davis; Jeffrey M Jentzen; Lena Napolitano; Javed Siddiqui; Lauren B Smith; Paul W Harms; Alexei A Grom; Randy Q Cron
Journal:  J Infect Dis       Date:  2015-11-23       Impact factor: 5.226

4.  The need for worldwide policy and action plans for rare diseases.

Authors:  John Forman; Domenica Taruscio; Virginia A Llera; Luis A Barrera; Timothy R Coté; Catarina Edfjäll; Désirée Gavhed; Marlene E Haffner; Yukiko Nishimura; Manuel Posada; Erik Tambuyzer; Stephen C Groft; Jan-Inge Henter
Journal:  Acta Paediatr       Date:  2012-05-11       Impact factor: 2.299

Review 5.  Avian influenza A H5N1 virus: a continuous threat to humans.

Authors:  Kelvin Kw To; Kenneth Hl Ng; Tak-Lun Que; Jacky Mc Chan; Kay-Yan Tsang; Alan Kl Tsang; Honglin Chen; Kwok-Yung Yuen
Journal:  Emerg Microbes Infect       Date:  2012-09-19       Impact factor: 7.163

6.  Virus-associated hemophagocytic syndrome as a major contributor to death in patients with 2009 influenza A (H1N1) infection.

Authors:  Gernot Beutel; Olaf Wiesner; Matthias Eder; Carsten Hafer; Andrea S Schneider; Jan T Kielstein; Christian Kühn; Albert Heim; Tina Ganzenmüller; Hans-Heinrich Kreipe; Axel Haverich; Andreas Tecklenburg; Arnold Ganser; Tobias Welte; Marius M Hoeper
Journal:  Crit Care       Date:  2011-03-02       Impact factor: 9.097

7.  Virus-host interactomics: new insights and opportunities for antiviral drug discovery.

Authors:  Benoît de Chassey; Laurène Meyniel-Schicklin; Jacky Vonderscher; Patrice André; Vincent Lotteau
Journal:  Genome Med       Date:  2014-11-29       Impact factor: 11.117

Review 8.  Extracorporeal membrane oxygenation for acute respiratory distress syndrome.

Authors:  Toshiyuki Aokage; Kenneth Palmér; Shingo Ichiba; Shinhiro Takeda
Journal:  J Intensive Care       Date:  2015-06-17

Review 9.  Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis.

Authors:  Alimuddin Zumla; Martin Rao; Ernest Dodoo; Markus Maeurer
Journal:  BMC Med       Date:  2016-06-15       Impact factor: 8.775

Review 10.  Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options.

Authors:  Alimuddin Zumla; Ziad A Memish; Markus Maeurer; Matthew Bates; Peter Mwaba; Jaffar A Al-Tawfiq; David W Denning; Frederick G Hayden; David S Hui
Journal:  Lancet Infect Dis       Date:  2014-09-01       Impact factor: 25.071
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.